Investigators also want to combine ipilimumab with drugs that attack the tumour directly.
研究者也设想将ipilimumab和直接进攻肿瘤的药物结合使用。
2
These two researchers have been running a full-scale clinical trial of ipilimumab, an antibody that stimulates patients' immune systems to kill tumours.
Almost a quarter of those treated with ipilimumab were alive two years after treatment started. That compared with 14% of those treated just with the vaccine.